2023. In Silico Assessment of Chemical Constituents of Zingiber officinale Rosc. For Anti-diabetic Activity: Molecular Docking with α-Glucosidase Receptor. Pharmaceutical and Biomedical Sciences Journal (PBSJ). 5, 2 (Dec. 2023), 132–142. DOI:https://doi.org/10.15408/pbsj.v5i2.36161.